Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria.
Despite inadequacy in preventing vivax malaria after travel, suppressive chemoprophylaxis has dominated travel medicine strategy since the advent of chloroquine in 1946. The lethal threat of falciparum malaria versus the perceived benign consequence of vivax malaria underpins this strategic posture....
প্রধান লেখক: | Baird, J |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
2013
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria
অনুযায়ী: Baird, J
প্রকাশিত: (2013) -
Management of Plasmodium vivax risk and illness in travelers
অনুযায়ী: Baird, J
প্রকাশিত: (2017) -
Management of Plasmodium vivax risk and illness in travelers
অনুযায়ী: J. Kevin Baird
প্রকাশিত: (2017-03-01) -
Neglect of Plasmodium vivax malaria.
অনুযায়ী: Baird, J
প্রকাশিত: (2007) -
“Lively” invasive Plasmodium vivax causes severe and complicated malaria
অনুযায়ী: Baird, J
প্রকাশিত: (2019)